Amanote Research

Amanote Research

    RegisterSign In

BiTE Therapy Active in Multiple Myeloma

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2019-001
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

January 8, 2019

Authors

Unknown

Publisher

American Association for Cancer Research (AACR)


Related search

Lipid Raft-Targeted Therapy in Multiple Myeloma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2010English

Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma

International Journal of Hematology
Hematology
2020English

GPRC5D CAR T-Cell Therapy Has Antitumor Activity in Multiple Myeloma

Cancer Discovery
Oncology
2019English

Frontline Therapy in Multiple Myeloma: Fast Start for a Long Game

The Lancet Haematology
Hematology
2019English

Prognostic Significance of Upfront Radiation Therapy in Patients With Multiple Myeloma

American Journal of Hematology
Hematology
2019English

MET/HGF Pathway in Multiple Myeloma: From Diagnosis to Targeted Therapy?

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2015English

Effect of Thalidomide Therapy on Bone Marrow Angiogenesis in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Multiple Myeloma

Annals of Internal Medicine
Internal MedicineMedicine
1942English

Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy